Non-ionic iodinated contrast media related immediate reactions: A mechanism study of 27 patients.

Journal: Legal medicine (Tokyo, Japan)
Published Date:

Abstract

The underlying mechanism of non-ionic iodinated contrast media-related immediate reactions was evaluated in this study. Patients presenting at least grade II immediate reactions after non-ionic iodinated contrast media injection were enrolled. Basophil activation was evaluated by flow cytometry. The plasma concentration of human terminal complement complex SC5b-9, as well as concentrations of serum chymase, tryptase, human mast cell carboxypeptidase A3, human prostaglandin D2, and total IgE were measured by enzyme-linked immunosorbent assay. The basophil activation percentage was significantly higher in the study group than in the control group (17.94±21.06% vs 3.45±1.49%). The plasma concentration of human terminal complement complex SC5b-9 and concentrations of serum chymase, human mast cell carboxypeptidase A3, prostaglandin D2, tryptase, and total IgE were also significantly increased (236.99±318.21 vs 49.70±30.41ng/mL, 0.41±0.49 vs 0.09±0.06ng/mL, 1.17±0.67 vs 0.30±0.17ng/mL, 203.52±137.27 vs 102.28±48.72pg/mL, 3.81±0.22 vs 2.70±0.16ng/mL, 102.00±51.84 vs 19.97±2.75ng/mL, respectively). Both mast cells and basophils were activated in non-ionic iodinated contrast media to mediate immediate hypersensitivity, and mast cells may be involved. Different mechanisms, including IgE-dependent, complement-dependent, and direct membrane effects, contributed to mast cell and basophil activation. Individual patients may use a single or combined mechanism involving single or combined mast cells and basophils. Immediate reactions following non-ionic iodinated contrast media injection may be a mechanically heterogenous disease.

Authors

  • Liqin Zhai
    Department of Pathology, School of Forensic Medicine, Shanxi Medical University, Taiyuan 030001, China; Department of Pathology, Shanxi Provincial Hospital, Taiyuan 030012, China.
  • Xiangjie Guo
    Department of Pathology, School of Forensic Medicine, Shanxi Medical University, Taiyuan 030001, China.
  • Haoyue Zhang
    Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA.
  • Qianqian Jin
    Department of Pathology, School of Forensic Medicine, Shanxi Medical University, Taiyuan 030001, China.
  • Qiang Zeng
    State Key Laboratory of Environment Health (Incubation), Key Laboratory of Environment and Health, Ministry of Education, Key Laboratory of Environment and Health (Wuhan), Ministry of Environmental Protection, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, #13 Hangkong Road, Wuhan, Hubei 430030, China.
  • Xiaoxian Tang
    Department of Computer Tomography, Shanxi Provincial Hospital, Taiyuan 030012, China.
  • Cairong Gao
    Department of Pathology, School of Forensic Medicine, Shanxi Medical University, Taiyuan 030001, China. Electronic address: caironggao@126.com.